Date: 5-6 September 2022

Location: Veyrier-du-Lac, France

Organiser

Paediatric working group, ESCMID Study Group for Antimicrobial Stewardship (ESGAP)

Module objectives

Although providing advice on the management of children with infections (both common and complex infections) falls within the routine workload of clinical microbiologists and antimicrobial pharmacists working in general hospitals across Europe, there are many fundamental differences between adults and children that impact on decision making. Not only are children vulnerable to a number of pathologies that most adults are protected from, the aetiology and presentation of infection in children often differs considerably. Sample collection in children can be extremely challenging and the effect of the microbiota can limit the utility of many tests in children. For these reasons, many microbiologists and clinical pharmacists feel less confident proving advice on children compared to adults, potentially resulting in unnecessary investigations, prolonged exposure to antimicrobials and diagnostic delays. This course aims to address some of these issues through a series of case-based interactive workshops. Active participation will be maintained through on-line discussions and real-time voting. Key differences between children and adults will be highlighted and evidence based approaches to managing children will be presented. Discussions within these workshops will include the role of lumbar puncture in young infants with UTIs, conservative versus surgical management of atypical mycobacterial lymphadenitis in children, the role of pneumococcal urinary antigen testing in children with pneumonia, whether routine echocardiography is required in all children with staph aureus bacteraemia, investigating the baby with late onset sepsis, managing children following a significant exposure to pulmonary TB and many others. This approach has been used annually at the annual UK Federation of Infection Society (FIS) meeting and has received excellent feedback from microbiologists.

Module venue

Les Pensieres,
55 route d'Annecy,

74290 Veyrier-du-Lac,

France

Preliminary programme

*This module programme is subject to minor amendments

DAY 1

09:00 – 09:30                  

Overview of the course and introductions Dr Sanjay Patel

09:30-10:15              

Paediatric AMS - the differences between children and adults Dr Julia Bielicki

COMMON INFECTION PHENOTYPES

10:30 - 11:15        

*Complex pneumonia                  Dr Sanjay Patel

11:30 – 12:15                

*Atypical mycobacterial lymphadenitis        Dr Gaud Catho

12.15 - 2pm

LUNCH

14:00-14:45        

*Urinary tract infections                Dr Sanjay Patel

15:00 – 15:45           

*Osteoarticular infections      Dr Elias Iosifidis

16:00 - 16:45                  

*Meningitis and encephalitis in children – are rapid diagnostics friends or foes?    Dr Julie Toubiana

16:45 – 17:00    

FEEDBACK AFTER DAY 1

*Interactive, case based session

DAY 2

09:30-10:15        

Implementing a paediatric antimicrobial stewardship service – role of the multidisciplinary team    Dr Julia Bielicki

RARER INFECTION PHENOTYPES

10:30-11:15        

*Managing CLABSI in children      Dr Julie Toubiana

11:30 – 12:15        

*Investigating the child with prolonged fever  Dr Elio Castagnola

12.15-14:00

LUNCH

14:00-14:45            

*Sepsis in the neonate (late onset sepsis)          Dr Elias Iosifidis

15:00-15:45                  

*Invasive fungal infections in neonates        Dr Elio Castagnola

16:00-16:45        

*Significant exposure to pulmonary TB in a child  Dr Gaud Catho

16:45-17:00pm

FEEDBACK AFTER DAY 2

*Interactive, case based session

Programme coordinator contact

Dr Sanjay Patel
Southampton Children's Hospital,

Southampton,
United Kingdom
 

Date: 23-25 January 2023

Location: Online

Organisers

Bichat Claude Bernard Hospital, University of Paris, IAME, Inserm; in partnership with Doctors Without Borders (MSF), Imperial College London, United Kingdom, University of Cape Town, South Africa and University of Bobo Dioulasso, Burkina Faso

Module objectives

Understand the issues and challenges of AMS in LMICs, to enable participants to better adapt the concepts learned in the other modules to these specific contexts, based on the example of several specific initiatives and solutions. The module will cover three themes: the context (Epidemiology of AMR and Antimicrobial prescription in LMICs); the implementation of AMS programs in LMICs; and the perspectives (researches, innovations, and training programs). This is aimed either at participants wishing to practice directly in these fields, or at those working on global health issues.

Preliminary programme

*This module programme is subject to minor amendments

Day 1

Context of AMS in LMICs

AM

Epidemiology of AMR in LMICs

 

9:00-9:30

Welcome: introduction to the module, presentation of speakers and participants

Organizing committee

9:30-10:30

Context and epidemiology of AMR in LMICs :
- General introduction (1h)
- Challenges for the surveillance (30 min)

Prof Marc Mendelson (University of Cape Town, South Africa)

Dr Christelle Elias (Fondation Mérieux, France)

 Break

11:00-12:30

What are the factors leading to AMR in these specific contexts ?
Short presentations (30 min x2) followed by a Q&A session :
- Emergence of AMR in human medicine : examples and issues (Institut Pasteur)
- Emergence of AMR in One Health : examples and issues (FAO)

Moderator : Prof Serge Eholié (University of Abidjan-Treichville , Ivory Coast)

Dr Violeta Moya (Institut Pasteur, France)

Dr Rodolphe Mader (FAO, Thailand)

PM

Antimicrobial prescribing in LMICs

14:00-15:00

Determinants of antimicrobial prescribing in LMICs - behavioural science insights

Dr Esmita Charani (Imperial College & University of Cape Town, UK & South Africa)

15:00-16:30

Specific issues of antimicrobial prescribing in LMICs
Short presentations (20 min x3) followed by a Q&A session :
- Market regulation, Overall consumption,
- Fake drugs, automedications
- Current situation of antibiotic guidelines in LMICs

Moderator : Dr Christian Mouala (UNAIDS, Haïti)

Dr Mirfin Mpundu (ReAct Africa, Zambia)

Dr Carine Baxerres (IRD, France)

Dr Christelle Elias (Fondation Mérieux, France)

 Break

17:00-18:00

Overview of existing programs and initiatives on AMS:
- General components of AMS : Microbiology, IPC, Advice for Antibiotic prescription, Stewardship
- Avaibility of AMS programs worldwide

Prof Christian Lienhardt (IRD, France)

Dr Nusrat Shafiq (PGIMR Chandigarh, India)

18:00-18:30

National action plans around the world: what for AMS?

Dr Esmita Charani (Imperial College & University of Cape Town, UK & South Africa)

 

Day 2

Implementation of AMS in LMICs

9:00-11:00

Local hospitals programs and operational challenges
- examples for the African context
- examples for the Asian context

Prof Armel Poda (University of Bobo Dioulasso, Burkina Faso)

Prof Salou Mounero (University of Lome, Togo)

Prof Sanjeev Singh (Amrita Institute of Medical Sciences, India)

 Break

11:30-12:30

AMS in primary care :
- From HIV to AMS programs : examples of community approachs
- Organization of the healthcare system and health pyramid

Dr. Etienne Guillard (Solthis, Senegal-France)

Prof Sanjeev Singh (Amrita Institute of Medical Sciences, India)

14:00-15:00

General strategy of MSF programs in AMS:
IPC / Microbiology / AMS / Epidemiological surveillance

Dr Rupa Kanapathipillai (MSF, USA)

15:00-16:30

MSF projects and operational challenges :
- examples from African contexts
- examples from Middle-East contexts

Dr Bastien Mollo (MSF & Bichat, France)

Dr Marion Dollat (MSF, France)

 Break

17:00-18:30

Difficulties and obstacles of AMS in LMICs and/or in humanitarian contexts :
- Personal examples from participants
Roundtable

Moderators : Dr Manica Blasegaram (GARDP, Switzerland)

Prof Aristophane Tanon (University of Abidjan-Treichville , Ivory Coast)

Speakers of the day, and participants

 

Day 3

Perspectives for AMS in LMICs

AM

Research and innovations

9:00- 11:00

Research on AMS in the LMICs:
Short presentations (30 min x3) followed by a roundtable:
- Challenges to implement clinical trials (Epicenter-MSF)
- Challenges for epidemiological surveys (Institut Pasteur)
- Challenges for microbiological development (Bichat-INSERM)

Moderator : Prof Yazdan Yazdanpanah (Bichat-ANRS-MIE, France)

Dr Céline Langendorf (Epicentre-MSF, France)

Dr Bich-Tram Huynh (Institut Pasteur, France)

Pr Laurence Armand (Bichat-INSERM, France)

 Break

11:30-12:30

An innovation by MSF : the MiniLab :
- Concept, microbiological aspects, implementation on the field
- AMS consequences

Jean-Baptiste Ronat (MSF MiniLab, France)

Dr Kerry Dierberg (MSF, USA)

PM

Training and skill transfer

13:30-14:30

Clinical Desision Support System and applications for antimicrobial prescribing in LMICs
- Example of "Antibioclic Afrique" and its evaluation
- Example of "e-Care" and its implementation

Dr Corinne Akpovo (University of Abidjan-Treichville , Ivory Coast)

Dr Nathan Peiffer-Smadja (Bichat-INSERM & Imperial College, France & UK)

Clothilde Rambaud (eCare - MSF, Switzerland)

 Break

15:00-17:00

Training programs : issues and challenges
Short presentations (20 min x 4) followed by a roundtable :
- e-learning (MSF-Academy)
- Onsite training (University Diploma for Sub-Saharan Africa)
- Innovative pedagogies: Serious games (Dawaa; BacteriaGames), Simulation

Moderator : Prof Xavier Lescure (Bichat-INSERM, France)

Dr Bart Janssens (MSF-Academy, Netherlands)

Prof Abdoul Salam Ouedraogo (University Nazi Boni, Burkina Faso)

Dr Liem Luong (INSERM, France), Dr Mathilde Lescat (INSERM, France)

Dr Bastien Mollo (Bichat & MSF, France)

17:00-18:00

Conclusion and discussions

Organizing committee

Programme coordinator contact

Dr Bastien Mollo

Service des Maladies Infectieuses et Tropicales du Pr Yazdan YAZDANPANAH,

Hôpital Bichat,

Paris,

France

 

Dr Nathan Peiffer-Smadja

Service des Maladies Infectieuses et Tropicales du Pr Yazdan YAZDANPANAH,

Hôpital Bichat,

Paris,

France

Date: 17-19 March 2023

Location: Homburg/Saar, Germany

Organisers

Institute of Medical Microbiology and Hygiene, Saarland University, Homburg/Saar, Germany

Module objectives

Processes of globalisation and climate change have far-reaching consequences, which affect medical care worldwide. Steadily rising temperatures and climate change-induced natural disasters lead to changing mobility patterns and migration movements of refugees. Furthermore, infectious diseases may become prevalent in regions that have not been affected previously. Antimicrobial stewardship, especially for migration- and travel-associated infections, should therefore be taught with a global and holistic perspective, taking medical, political, and cultural factors into account. The aims of the course are to (i) enable participants to diagnose and classify infectious diseases in the context of travel and migration, (ii) develop diagnostic strategies and treatment options for selected travel- and migration-associated infections, and (iii) apply the AMS concept specifically to health problems associated with migration, One Health and climate change.

Module venue

Saarland University Medical Centre Homburg,

Kirrberger Strasse,

Building 43,

66421 Homburg/Saar,

Germany

Preliminary programme

*This module programme is subject to minor amendments

Day 1

15:00 – 15:45

Climate Aspects in AMR/AMS and migration

Dr August Stich

15:45 – 16:30

Travel-associated Staphylococcus aureus infections: clinical pictures and diagnostics

Dr Sören Becker

16:30 – 17:00

Coffee break

17:00 – 17:45

Diagnostics and epidemiology of PVL+ S. aureus: implications for AMS

Dr Dennis Nurjadi

17:45 – 18:30

War refugees - experiences with MDR infections Dr August Stich

18:30

Dinner

Day 2

08:30 – 09:30

AMS aspects in TB diagnostics and resistance detection

Dr Harald Hoffmann

09:30 – 10:30

TB: Migration and clinical images

Dr Barbara Kalsdorf

10:30 – 11:00

Coffee break

11:00 – 11:30

TB Projects: Strategies to improve compliance in the outpatient setting

Dr Michael Knipper

11:30 –12:30

AMR in the tropics and subtropics – implications for AMS in Europe

Dr Martin Grobusch

12:30 – 13:30

Lunch

13:30 – 14:30

Pre- and Post-travel - What to take into account regarding AMS?

Dr Anu Kantele

14:30 --15:30

Parasite diagnostics in migrants and travellers with particular emphasis on resistance

Dr Lisette van Lieshout

15:30 – 16:00

Coffee break

16:00 – 17:00

Migration and travellers - Long-term infectious disease consequences and the impact on AMS

Dr Emmanuel Bottieau

17:00 –18:30

Participant presentations in small groups on AMS cases/ issues with expert discussion

18:30

Dinner

Day 3

09:00 – 10:00

One Health and AMR? Lessons learned?

Dr Fabian Leendertz

10:00 – 11:00

Sustainable pharmacy and AMR - is there a connection? - Implications for AMS

Dr Michael Müller

11:00 – 11:30

Coffee break

11:30 – 12:30

AMS in the Tropics - Internationally Applied AMS Interfaces

Dr Valérie D’Acremont

12:30 –13:30

Cultural concepts of being ill and receiving therapy – factors influencing communication behaviour

Dr Hannah Brown

13:30 – 14:30

Lunch

Departures

Programme coordinator contact

Katharina Last / Dr. med. Sophie Schneitler
Institute of Medical Microbiology and Hygiene,

Saarland University

Homburg/Saar,

Germany

Date: 10-13 May 2023

Location: Seville, Spain

Organisers

Hospital Universitario Virgen Macarena

Module objectives

1. To learn how an antimicrobial stewardship programme (ASP) was designed
and implemented in a specific setting (University hospital with a low rate of multidrug-resistant
organisms [MDRO] located in Southern Europe)

2. To observe and learn how the ASP interventions are performed in real life in the different clinical settings and scenarios, with the
available resources

3. To discuss how to measure the impact of the interventions

4. To understand the importance of the synergy between infection control and ASP

Module venue

Hospital Universitario Virgen Macarena,

Avd. Dr. Fedriani n 9,

41009, Seville, Spain

Preliminary programme

*This module programme is subject to minor amendments

Day 1

16.00-16.45

Welcome and Introduction Lecture: Developing the ASP and Infection Control programme at HUVM: synergy to control antimicrobial resistance

Jesús Rodriguez-Baño

16.45-17.00

Role of the Clinical Microbiologist in ASP and Infection Control Team

Lorena López-Cerero

Day 2

8.30-9:00

Global perspective of ASP and Infection Control in multidrug-resistant low incidence settings: introduction and explanation of the course dynamics.

Pilar Retamar-Gentil

9:00-10.30

Round 1: intervention in different settings: Haemato-Oncology; Bacteraemia and OPAT; Intensive Care; Surgical Departments; Infection Control; Pharmacy.

All faculties

10.30

Coffee

 

11:00-12.30

Round 2: intervention in different settings: Haemato-Oncology; Bacteraemia and OPAT; Intensive Care; Surgical Departments; Infection Control; Pharmacy.

All faculties

12.30-14:00

Round 3: intervention in different settings: Haemato-Oncology; Bacteraemia and OPAT; Intensive Care; Surgical Departments; Infection Control; Pharmacy.

All faculties

14:00-15:00

Lunch

 

15:00-16.30

Round 4: intervention in different settings: Haemato-Oncology; Bacteraemia and OPAT; Intensive Care; Surgical Departments; Infection Control; Pharmacy.

All faculties

16.30-18:00

Barriers and solutions to implement ASP interventions in specific settings and circumstances.

Dr. Joserra Paño-Pardo

Day 3

9-10.30

Round 5: intervention in different settings: Haemato-Oncology; Bacteraemia and OPAT; Intensive Care; Surgical Departments; Infection Control; Pharmacy.

All faculties

10.30

Coffee

 

11-12.30

Round 6: intervention in different settings: Haemato-Oncology; Bacteraemia and OPAT; Intensive Care; Surgical Departments; Infection Control; Pharmacy.

All faculties

12.30

Conclusions and Farewell

 

Programme coordinator contact

Pilar Retamar-Gentil
Hospital Virgen Macarena,

Seville,

Spain

 

Date: 18-19 May 2023

Location: Poitiers, France

Organisers

University hospital of Poitiers / University hospital of Lille

Module objectives

The aim of the module is to ensure an understanding of:

  • Pharmacokinetics: knows and understands the pharmacokinetics of antibiotics related to AMS
  • Extracellular/intracellular distribution of antimicrobials and its implication for antibiotic prescribing
  • Pharmacodynamics: knows the mechanism of action of antimicrobials, their clinically relevant antimicrobial spectra, and understands the pharmacodynamics properties important for antimicrobial dosing
  • Allergy: knows and understands the pathogenesis of allergy to antimicrobials and its clinical presentation, and can plan the therapy to avoid the risk of allergy, knows the principles of de-labelling and as a leader be capable of organizing de-labelling in their setting
  • Availability of antimicrobials: knows the antimicrobials listed in the formulary in his setting and their trade names, contributes to proper inclusion of new antimicrobial drugs in the formulary, knows the risks of drug shortages and is capable to respond to the shortages according to the setting
  • The dose / dosing interval (incl. prolonged and continuous infusion): understands the benefits and risks of dosing schedules, can plan appropriate dosing schedules, and is able to explain them to the primary team and the patient
  • Dosing in renal failure, during various renal replacement therapies and during extracorporeal membrane oxygenation, in nebulizators
  • Knows how to adjust the dose of antimicrobials according to the changes in pharmacokinetic of antibiotics related to the patient condition (decreased renal and hepatic function, severe burns, oedema, etc.)
  • Therapeutic drug monitoring (TDM): understands the need for TDM, knows how the interpret the results, and as a leader is capable of organizing TDM in the setting
  • Knows and understands the statistical methods for the analysis of AMS interventions
  • Knows the IT resources available outside the workplace that may be useful for AMS and knows how to use them
  • Knows how to use IT support available in the setting to monitor and improve antimicrobial use
  • Knows and understands the use of information technology in surveillance, medication management, and AMS interventions (education, restrictions, drug approval)
  • Knows and understands the use of electronic clinical decision support, telehealth, and smartphone apps in antibiotic prescribing and AMS
  • Understands the benefits of computerized medical records including computerized prescribing of antimicrobials and contributes to the development and use of the programs

Preliminary programme

*This module programme is subject to minor amendments

Day 1

09:00 - 09:15

Welcome

09:15 - 11:00

Basic principles of PK/PD

François Jehl

11:00 - 11:20

Pause

11:20 - 12:00

Optimized PK/PD as a tool for AMS

Jason A. Roberts

12:00 - 13:30

Lunch

13:30 - 14:00

Modelling principles in antibiotics PK/PD

Femke de Velde

14:00 - 14:20

Antimicrobial dosing optimisation and kidney failure

Emmanuel Faure

14:20 - 15:20

Practical exercise on dose optimization

TBD

15:20 - 15:40

Antimicrobial dosing optimisation in specific populations, in particular immunocompromised patients

Emmanuel Faure

15:40 - 16:00

Information technology as a tool for antimicrobial stewardship (including shortages)

Guillaume Beraud

16:00 - 16:30

A comprehensive review of IT resources for AMS

Tim Rawson

16:30 - 16:50

Pause

16:50 - 17:10

A practical example of IT implementation for AMS,

Louis Valiquette

17:10 - 17:30

Big data to tackle AMR

Philippe Desprez

17:30 - 18:30

Practical exercise: Data science for antimicrobial stewardship

Christian Luz

19:00

Dinner and social event

 

Day 2

09:00 – 09:15

Welcome

Guillaume Beraud and Emmanuel Faure

09:15 – 11:00

Statistical methods to assess AMS interventions

Lander Willem

11:00 – 12:00

Practical exercise on analysing data

 

12:00 – 12:30

Antimicrobial allergy: Diagnostic and de-labelling as a tool for AMS

 

12:30

Lunch and conclusions of the seminar

Programme coordinator contact

Guillaume Beraud

University Hospital of Poitiers,

France

Date: October 2023

Location: Online

Organisers

Faculty of medicine, University Ss Cyril and Methodius Skopje & Institute for Social Innovation - Skopje

Module objectives

1. Recognizes problems that should be addressed in outpatient setting and is capable for addressing them by organizing appropriate structures, interventions, and monitoring
2. Understands the role of cultural and behavioral determinants in antibiotic prescribing in outpatient and primary care
3. Can recognize the facilitators and barriers to ASPs and is able to address them
4. Understands and can perform different communication techniques
5. Can communicate with all stakeholders involved in AMS at primary care level

Preliminary programme

*This module programme is subject to minor amendments

DAY 1 – Clinical “life” of antibiotics (1): policies, guidelines and practices

09:00 – 09:15

Welcome and introduction to the course

Prof Dr Katarina Stavrikj

09:15 – 09:45

How do we choose antibiotics in primary care?

Dr Milena Kostic

09:45 – 10:15

What do I use in my practice?

Survey results discussion – do’s and don’ts

Dr Milena Kostic

(Mentimeter tool)

10:15 – 10:30

BREAK

10:30 – 11:00

Empiric vs. diagnosis-based prescribing: challenges and pitfalls

Prof Dr Katarina Stavrikj

 

11:00 – 11:30

How do I prescribe? Discussion – do’s and don’ts

Prof Dr Katarina Stavrikj

(Mentimeter tool)

11:30 – 12:30

LUNCH BREAK

12:30 – 13:30

Evidence-based practical tools in primary care

Interactive Q&A and Discussion

Dr Milena Rovcanin

13:30 – 14:15

Upper respiratory infections and antibiotics Interactive Q&A and Discussion

Dr Dragan Georgievski

14:15 – 15:00

Urinary tract infections treatment in primary care

Interactive Q&A and Discussion

Dr Milena Kostic

15:00 – 15:45

Clinical and peer pressures: Assessment of empiric therapy prescribed by emergency services or another physician

Dr Milena Rovcanin

15:45 – 16:15

Clinical and peer pressures

Interactive Q&A and Discussion

Dr Milena Rovcanin (Mentimeter tool)

15:15 – 16:30

Conclusion of the day

Prof Dr Katarina Stavrikj

DAY 2 – Social “life” of antibiotics: prescribers, patients and physician-patient communication in prescribing

09:00 – 09:15

What are the main drivers of irrational prescribing?

Mentimeter survey

09:15 – 09:45

Communication skills with patients, community and general public

Dr Katarina Stavrikj

09:45 – 10:00

BREAK

10:00 – 11:00

Case study/Role play – parallel sessions

 

Session 1:

How to communicate with a parent of a feverish child?

Prof Dr Katarina Stavrikj

Dr Dragan Georgievski

Session 2:

How to communicate with a patient requesting antibiotics

Dr Katerina Kovacevikj

Dr Neda Milevska-Kostova

Work in groups

11:00 – 11:30

Role play discussion – do’s and don’ts

Dr Dragan Georgievski

Dr Neda Milevska-Kostova

11:30 – 12:30

Physician-patient relationship: Protocols for continued communication (telemedicine)

Dr Katerina Kovacevikj

12:30 – 13:30

LUNCH BREAK

13:30 – 14:30

Patients and patience: lessons learnt from COVID-19

Prof Dr Katarina Stavrikj

Prof Dr Irena Kondova

14:30 – 15:00

Interactive Q&A and Discussion

 

15:00 – 16:00

Farewell and post-course assignments

All faculty

Programme coordinator contact

Prof Dr Katarina Stavrikj,

University Ss Cyril and Methodius Skopje,

Skopje,

Macedonia
 

Date: TBD, 2024

Location: Online

Organisers

ESCMID PK/PD of Anti-Infectives Study Group (EPASG), The European Committee on Antimicrobial Susceptibility Testing (EUCAST), The International Society of Anti-Infective Pharmacology (ISAP)

Module objectives

This course presents and summarises currently available knowledge on PK/PD of
commonly used antibiotics, strategies for setting clinical breakpoints, individualised dosing, and
therapeutic drug monitoring. The aim is to provide participants with insights that can be used to
optimise antibiotic therapy for different patient groups, infection sites and pathogens.

Preliminary programme

*This module programme is subject to minor amendments

Day 1

8:15-8.30

Registration

8.30-8.40

Welcome and introduction 

08:40-9:25

Basics of dosing (interactive) 

09:25-10.30

Why do we need to reconsider standard dosing regimens – dosing in special patient populations

10:30-11:00

Break

11:00 -11:45

Current strategies for MIC determination and setting clinical breakpoints

11:45-12:15

Population PK modelling for individualised dosing

12:15-13:15

Lunch

13:15-14:15

Preclinical infection models and what are the experimental and clinical data

supporting PK/PD targets? (Thomas

supporting PK/PD targets?

14:15- 14:45

Mathematical modelling of preclinical data to predict dosing strategies

14:45 -15.00

Break

15:00- 15.45

Optimal dosing and continuous or prolonged infusion of beta-lactams and vancomycin – what is the evidence?

15.45-16.30

How to optimise the use of aminoglycosides, quinolones and polymyxins; use of therapeutic drug monitoring (clinical case studies, interactive) 

 

Day 2

08:30-09:00

Optimised dosing regimens for antibiotic combinations 

09:00-09:45

Impact of tissue penetration and when should local administration of antibiotics be consisidered?

9:45-10:15

Principles of individualised dosing of antifungals based on therapeutic drug monititoring

10:15-10:45

Break

10:45-11:15

Using decision support systems for dosing of anti-infectives – chances and caveats

11:15-12:00

How to apply knowledge on PK/PD and TDM in clinical practice (interactive)

12:15-13:30

Lunch

13.30-14.15

How to apply knowledge on PK/PD and TDM in clinical practice (continued)

14.15-15:00

Future perspectives – clinical breakpoints and dosing in 20 years? 

15:00-15:30

Break

15.30-16:00

Closing remarks and any remaining questions 

Programme coordinator contact

Markus Zeitlinger
Medical University of Vienna,

Vienna,
Austria
 

 

Date: 5-6 April 2024

Location: Online

Organisers

Aster Medcity

Module objectives

At the end of the course, the participant will be able to:
- Understand the basics and need for AMS in their setting
- Develop and implement a AMS program relevant to their setting

Preliminary programme

*This module programme is subject to minor amendments

Day 1

 

 

Epidemiology of MDRO in LMIC setting

 

30 min

 

Dr Sneha Radha MD 
Empiric Therapy in MDRO endemic setting - Clinical Syndrome based approach

90 min

Dr Anup R Warrier FRCP, FIDSA 

Impact of MDRO endemicity on surgical prophylaxis

30 min

Dr Dipu T S (MD )
Targeted Therapy in MDRO endemic setting - Pathogen based approach

90 min

Dr Sneha Radha MD 

Day 2

 

 
Barriers and Drivers of AMSP in LMIC settings

30 min

Dr Merlin MD 
Strategies for AMSP Implementation in high MDRO endemicity under resource poor settings

30 min

Dr Arun Wilson MD 
Strategies for AMSP Implementation in high MDRO setting under resource rich setting

30 min

Dr Ravikant Porwal MD 
Rapid Diagnostics of HRMO in high endemic setting - Impact on AMSP

30 min

Dr Arun Wilson MD 
Antifungal Stewardship - Challenge of Candida auris 30 min Dr Merlin MD 
AMSP in high MDRO endemicity settings - An overview 30 min Dr Anup R Warier FRCP FIDSA

Programme coordinator contact

Dr Anup R Warrier
Aster Medcity

Kerala,

India